Lixte Biotech Hldgs Q4 EPS $(0.34) Down From $(0.27) YoY

Lixte Biotech Holdings reported a fourth-quarter loss of $(0.34) per share, which is a 25.93% increase in losses compared to $(0.27) per share in the same period last year.